Furthermore, using Mendelian randomisation analysis we report that genetically-predicted higher IL-6 activity and genetically-predicted lower CRP concentrations are associated with increased risk of depressive symptoms, suggesting that inflammation, particularly altered activity of the IL-6/IL-6R pathway, could be a risk factor for depression. Here, IL6 is linked to major depressive disorder.